HOPLITYX Trademark

Trademark Overview

On Thursday, April 28, 2022, a trademark application was filed for HOPLITYX with the United States Patent and Trademark Office. The USPTO has given the HOPLITYX trademark a serial number of 97386058. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 10, 2024. This trademark is owned by Allergan Pharmaceuticals International Limited. The HOPLITYX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat infections
hoplityx

General Information

Serial Number97386058
Word MarkHOPLITYX
Filing DateThursday, April 28, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations to treat infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan Pharmaceuticals International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin D17E400
IE
Party NameAllergan Pharmaceuticals International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin D17 E400
IE

Trademark Events

Event DateEvent Description
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 2, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022ASSIGNED TO EXAMINER
Thursday, October 13, 2022NON-FINAL ACTION WRITTEN
Thursday, October 13, 2022NON-FINAL ACTION E-MAILED
Thursday, October 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 19, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 19, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 19, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, April 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU EXTENSION 2 FILED
Wednesday, July 10, 2024SOU EXTENSION 2 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

hoplityx infections treat preparations pharmaceutical